CompletedNCT06372210
A Trial to Assess a Wearable Patch's Functioning to Detect Medication Ingestion
Medication studyAges 18+United StatesDepression
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- Garden GroveSee all locations and recruitment
Study information
Study start dateStarted: June 26, 2023
- Recruitment status
- Completed
- Enrollment listed in the registry
- 54
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Sponsor type
- Pharmaceutical company
- Study type
- Drug
- Intervention type
- DEVICE, Medication / drug
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT06372210
- Official title
Show the full official title
An Open-label, Prospective Trial Assessing Positive Detection Accuracy and Detection Latency Measures of the Miniature Ingestible Event Marker Tablet Using the D-Tect Patch in Healthy Subjects and Assessing Detection Latency Measures Using the D-Tect Patch in Subjects With Serious Mental Illness Taking Abilify MyCite Tablet
Get this study by email
Recruitment & locations
CompletedGarden Grove
Questions about this study
Who is behind this study?
The study sponsor is Otsuka Pharmaceutical Development & Commercialization, Inc., a pharmaceutical company.
Did this study involve medication?
Yes. The study involved medication, including Placebo IEM tablet and Abilify MyCite®.
Who was this study for?
Listed age limits: from 18 years.
